Tata 1mg refused to get carried away in the e-pharmacy battle. It’s in no mood to change its mind
The post Tata 1mg refused to get carried away in the e-pharmacy battle. It’s in no mood to change its mind appeared first on The Ken .
Tata 1mg, the digital healthcare company acquired by Tata Digital in 2021, is content with its current strategy and unwilling to alter its approach in the e-pharmacy market. Co-founder Vikas Chauhan shared a framed note from 2012, which outlined plans for diagnostics and retail clinics, demonstrating the company's long-term vision.
Despite declining to focus on quick deliveries and high discounts, 1mg has seen its revenue surge from Rs 309 crore to nearly Rs 3,000 crore in FY26. The brand is now not only profitable but also enjoys a 55% majority stake in its diagnostics vertical, which has achieved annualized revenue exceeding Rs 600 crore. In contrast, competitors like Pharmeasy and Netmeds have struggled under the pressure of aggressive discounting and debt-fuelled acquisitions, which have not yielded the desired results.
Written by urgent.news from The Ken's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
